Towards a more effective and efficient use of psychotropic drugs in - - PowerPoint PPT Presentation

towards a more effective and efficient use of
SMART_READER_LITE
LIVE PREVIEW

Towards a more effective and efficient use of psychotropic drugs in - - PowerPoint PPT Presentation

Towards a more effective and efficient use of psychotropic drugs in nursing homes: a quality improving project in Belgium Mir irko Petr trovic Department of Geriatrics Ghent University CONFLICT OF IN INTEREST DIS ISCLOSURE I have no


slide-1
SLIDE 1

Towards a more effective and efficient use of psychotropic drugs in nursing homes: a quality improving project in Belgium

Mir irko Petr trovic Department of Geriatrics Ghent University

slide-2
SLIDE 2

CONFLICT OF IN INTEREST DIS ISCLOSURE

I have no potential conflict of interest to disclose

slide-3
SLIDE 3
  • A trend for increased medication use in older people > 80
  • Multiple comorbidities resulting in increased risk for polypharmacy
  • Prescribing in Homes for the Elderly in BElgium

(PHEBE, 2006)

  • Cross-sectional study
  • Randomised, representative sample
  • 76 nursing homes
  • Medication + clinical data retrieved from the GPs
  • f 1730 residents
  • Consume an average of 7 chronic medications

Azermai, Elseviers M, Petrovic M et al.

  • Hum. Psychopharmacol Clin Exp 2011; 26: 12–20.

Prescribing in in Homes for th the Eld lderly in in BElg lgium

slide-4
SLIDE 4

Prescribin ing in in Homes for the Eld lderly ly in in Belg lgiu ium

KCE reports 47 A (D/2006/10.273/61)

10 20 30 40 50 60 70 80 90

One medication more than one

slide-5
SLIDE 5

Prescribing in in Homes for th the Eld lderly in in Belg lgium: Psychotropic dru rugs

8 33 40 54 20 40 60

Anti-dementia drugs Antipsychotics Antidepressants Benzodiazepines

%

Azermai M, Elseviers M, Petrovic M et al.

  • Hum. Psychopharmacol Clin Exp 2011; 26: 12–20.

The e prevale lence e is is excee ceedin ingly ly high igh (7 (79%) with ith fr freq equent use e of

  • f more

th than on

  • ne

e med edic ication

slide-6
SLIDE 6

Ass ssessment t of f antipsychotic prescribing in in nursing homes in in Bel elgium

  • Inappropriate prescribing :
  • long-term use (92.6%),
  • use despite the risk of fall

lls (45.6%),

  • combined use with other psychotropics (31.8%),
  • duplicate use (15.1%).

Azermai M et al Int Psychogeriatr2011; 23: 1240-1248

slide-7
SLIDE 7

How the project started …

2013 2013-2015 2015 ‘Project Psychotropic drugs’

  • Targeted at 1 NH, i.e. Leiehome
  • Educational sessions offered to all

employees at the start

  • Discontinuation of psychotropics

– From 72% to 48% use!

  • Comparative study with another NH

– Importance of project promoters for success!

  • Meaningful activities

2016 2016-2017 2017 ‘Together on

  • n th

the way to to le less ss’

  • Targeted at 5 pilot NHs
  • Roadmap with phase progression

– All ‘success elements’ of Leiehome were bundled

  • Preparation phase
  • Information phase
  • Realisation phase
  • Evaluation phase
slide-8
SLIDE 8

Aim ims of f the project

Efficient t us use Red educing cos

  • sts

ts No Non- ph pharm rmacological ap approach Ch Change of

  • f polic

policy Diss Dissemination of

  • f

sci cientifi fic in inform rmation

Towards a a mor

  • re

e effective an and effic icie ient use use of

  • f psychotropuc dru

drugs in n nur nursing hom homes: a a qua quality improvin ing pr proj

  • ject in

n Bel Belgium

Ra Raising of

  • f

awareness of

  • f

involv lved part partie ies

slide-9
SLIDE 9

Look before you leap.  Why that pill?  Each treatment has its length.  Together stronger!

Towards a mor

  • re effect

ective and effic ficien ent use of

  • f psych

chotropuc drug rugs in in nursin ing hom

  • mes: a quality

lity im improving proje ject in in Be Belgi lgium

slide-10
SLIDE 10

Depression

 Sorrow is not depression.  History of major depression?  Start low, go slow!

Towards a mor

  • re effect

ective e and effic ficien ent t use e of

  • f psych

chotropuc drug rugs in in nursin ing hom

  • mes: a quality

lity im improving proje ject in in Be Belgi lgium

slide-11
SLIDE 11

Towards a mor

  • re effect

ective e and effic ficien ent t use e of

  • f psych

chotropuc drug rugs in in nursin ing hom

  • mes: a quality

lity im improving proje ject in in Be Belgi lgium

Challenging behaviour

 Watchful waiting  Handle a problem, but not only with pills  Write down what you see, not what you think or feel!

slide-12
SLIDE 12

Towards a mor

  • re effect

ective e and effic ficien ent t use e of

  • f psych

chotropuc drug rugs in in nursin ing hom

  • mes: a quality

lity im improving proje ject in in Be Belgi lgium

Sleep- & anxiety problems

 Sleep hygiene and exercise  Anxiety has many causes  Avoid BZD³

slide-13
SLIDE 13

Methods

  • A pilot project (2013-2014) with a pre-post design in 2 nursing

homes

  • The intervention group received three educational sessions given

by experts on psychotropic drugs, in addition to one-on-one professional support provided by 2 project staff members (0.4 FTE)

  • The control group received education-only without professional

support afterwards

  • Drug use was recorded and coded according to the Anatomical

Therapeutic and Chemical classification

  • Psychotropics included: antipsychotics, benzodiazepines and

antidepressants

  • Measurements were done at 3 time-points: at baseline (pre), after

10 months (post) and after 1 year (follow-up)

Azermai M et al. Acta Clin Belg 2017; 73: 163-171.

slide-14
SLIDE 14

Results

  • Mean age of the residents (n=119) was 81

(range 56-96)

  • 71% were females
  • Dementia was the main clinical diagnosis

(35%)

  • Residents had a high physical dependency

with a mean ADL score of 17/24

  • Mean medication use at baseline was 9

(range 1-21)

slide-15
SLIDE 15

Psychotropic dru rug use in interv rvention group (n (n=119)

Prevale lence PRE RE 72 72.3 .3% Prevale lence PO POST 60.5 60.5%

Distribution of psychotropics Pre Distribution of psychotropics

slide-16
SLIDE 16

50 38 33 42 36 32 21 17 20

Pre Post 1 year later

Benzodiazepines Antidepressiva Antipsychotica

%

Range BZD 1-3 Range APS 1-2 Range AD 1-2

Pre, Post and 1 1 year la later

slide-17
SLIDE 17

50 42 20 38 36 17 58 44 30 53 41 28 10 20 30 40 50 60 70 Benzodiazepines Antidepressants Antipsychotics Intervention PRE Intervention POST Control PRE Control POST

%

Co Comparis ison with ith contr trol l nursin sing home

slide-18
SLIDE 18

Conclu lusions

  • Significant decrease in the use of psychotropic drugs

which remains tenable after 1 year follow-up

  • Education only has a limited effect
  • The person-centered approach by project staff is an

important added value

  • Room for improvement

– Prevalence of 60.5% remains high – Multiple use of psychotropics – Additional efforts are needed regarding antipsychotics

slide-19
SLIDE 19

33,7% 17,9% 9,5%

Total =61%

1 psychotropic 2 psychotropics 3 psychotropics

Use of f psychotropic dru rugs 1 1 year la later

slide-20
SLIDE 20
  • Evolution of total psychotropic drug use

51%

2016

72%

2013

61%

2014

52%

2015

48%

2017

Results of the NH Leie iehome 2013-2017

slide-21
SLIDE 21

Projectjaar 2015

Non-pharmacological approach (i.e. meaningful activities) and its impact on psychotropic drug use Analysis of the findings Expansion of the project

Continuation of f the project Continuation of f the project

slide-22
SLIDE 22

Meaningful Activ ivities

 Client centred  Activity oriented  Participatory attitude  Systematics & process  Interactive process

slide-23
SLIDE 23
  • Development and maintaining of

meaningful activities

  • For a selected sample:
  • 2 parts

–All new residents –Residents who already reside in the NH, divided into groups according to length of stay

Setup of f Meaningful Activ ivities

slide-24
SLIDE 24
  • Inclusion criteria for both:

–Cognitively competent residents, operationalized via MMSE > 18/30 –Katz scale O–A-B

  • Exclusion criteria:

–Residents with dementia operationalized via diagnosis and Katz profile D –Residents receiving palliative care

Sample cri riteria

slide-25
SLIDE 25
  • Testing started in October 2016
  • Intervention during 5 months, followed by post-

measurement

  • Sample consecutively and systematicaly

enlarged

In Intervention peri riode

slide-26
SLIDE 26

Variables Baseline Participants’ characteristics Gender (male/female) (n) 10/26 Age, years (mean; SD) 86,83; 5,40 Length of stay, months (mean; SD) 27,4; 38,99 KATZ-profiles (n/%) O A B C 10 (27,78 %) 11 (30,56 %) 10 (27,78 %) 5 (13,89 %) Cognition (MMSE) (mean; SD) 25,95; 2,53 Risk of depression (GDS > 1/5) n(%) 12 (33,33%) Mobility (EMS) (mean; SD) 13,66; 5,36

Meanin ingful Activ ivit ities

slide-27
SLIDE 27

Var aria iable les Ba Baselin seline Pos

  • st-

meas asurement p-valu alue Out utcomes Number of household activities (mean; ±SD) Number of hobbies and recreational activities (mean; ±SD) Total number of activities (mean; ±SD) 2,74; ±1,67 11,83; ±8,34 14.57 ±8.62 10,51; ±6,38 8,63; ±6,81 19.14 ±10.37 <0, <0,001 01 0,114 0.108 Satisfaction with the NH-environment (NH Active Ageing Questionnaire) (mean; ±SD) Culture Life style Psychological aspects Physical environment Social environment Economic aspects Care Animation Participation 77,96; ±11,02 76,94; ±10,00 71,67; ±11,97 79,17; ±7,49 66,89; ±11,87 66,48; ±15,90 78,33; ±10,44 67,50; ±11,79 70,33; ±8,60 73,16; ±8,33 77,59; ±12,26 74,26; ±10,22 74,44; ±12,27 76,54; ±6,81 71,33; ±9,00 70,93; ±12,66 77,31; ±10,70 72,57; ±11,01 72,11; ±10,14 74,01; ±7,74 0,858 0,129 0,251 0, 0,07 072* 0, 0,05 059* 0, 0,07 070* 0,493 0, 0,027 027 0,333 0,482

Meanin ingful Activ ivit ities

slide-28
SLIDE 28

Var aria iable les Base Baseli line Pos

  • st-

me measurement p-valu lue Medication use (mean; ±SD) Number of medications Psychotropics Antidepressants Benzodiazepines Antipsychotics 9,4; ± 5,01 1,06; ± 0,98 0,39; ± 0,55 0,50; ± 0,65 0,17; ± 0,38 9,2; ± 5,19 0,72; ± 0,91 0,22; ± 0,42 0,44; ± 0,69 0,08; ± 0,28 0,648 0,008 0,032 0,487 0,08 ,083

Meanin ingful Activ ivit ities

slide-29
SLIDE 29

Course of f th the project in in 5 pilo ilot NHs

Okt 2015 – Aug 2016 Voorbereidingsfase Sept – Okt 2016 Informatiefase Nov 2016 – Sept 2017 Interventiefase Oktober 2017 Evaluatiefase

1. Education 2. Inventorisation 3. Discontinuation 1. Hypno-sedatives 2. Antidepressants 3. Antipsychotics 4. Application 1. Data collection 2. Final picture

slide-30
SLIDE 30

Afbouwen?

  • Motivating residents to discontinue
  • Preparing a withdrawal scheme together with the

physician

  • Offering non-pharmacological alternatives to

residents

  • Providing support to residents during and after

discontinuation

  • Acting preventively: initiating of medication

appropriate?

Dis iscontinuation

slide-31
SLIDE 31

In Interim evaluation, May 2017

  • Roadmap feasible to follow and use in five pilot NHs

– Sometimes with small amendments by the project promoters

  • Resistance by staff members started to decrease during

the discontinuation phase

  • Discontinuation of hypno-sedatives successful in four

NHs

– Positive results by residents: more alert and active…

  • Success stories regarding Meaningful Activities have

been collected

slide-32
SLIDE 32

On the agenda

  • So far, the project has been limited to processes at

the level of the NH (= change of attitude)

  • Analyze the impact on individual residents, i.e. the

characteristics of residents that succeed in discontinuation of psychotropic drugs and those who don’t succeed

  • Analyze impact on patient-related outcomes in

connection with psychotropic discontinuation/reduction

slide-33
SLIDE 33

On the agenda

  • Collection and analysis of the results in 5 pilot NHs
  • Focus on prevention, i.e. by assessing:

– Impact on quality of life – Impact on fall ll incidents – Impact on health care related costs

  • Simulation figures NH Leiehome: annual savings of €

6,000 (public price incl. copayment)

slide-34
SLIDE 34

On the agenda

  • Amending roadmap
  • Integration of Meaningful Activities
  • Transfer of expertise, methods, enlarging network;

focus on prevention

  • Facilitating further roll-out
  • Research